Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Chemours Q2 Adj $0.38 Misses $0.57 Estimate, Sales $1.54B Beat $1.53B Estimate

Author: Benzinga Newsdesk | August 01, 2024 04:28pm
Chemours (NYSE:CC) reported quarterly earnings of $0.38 per share which missed the analyst consensus estimate of $0.57 by 33.33 percent. This is a 65.45 percent decrease over earnings of $1.10 per share from the same period last year. The company reported quarterly sales of $1.54 billion which beat the analyst consensus estimate of $1.53 billion by 0.52 percent. This is a 6.22 percent decrease over sales of $1.64 billion the same period last year.

Posted In: CC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist